<h1>Agrochem company forecasts 22% revenue growth to Rs2,200 crore by FY26, aims debt-free status, seeks private equity funding</h1> An India-based agrochemicals company projects a 22% revenue increase to Rs 2,200 crore for FY26, citing favorable monsoon, patented product launches and strong demand; it expects to become debt-free by next fiscal and plans private equity funding rather than an IPO. The firm has introduced multiple patented herbicide and insecticide products, anticipates significant sales from a new paddy insecticide, and is expanding manufacturing capacity across states funded by internal accruals. Legal and regulatory points include reliance on patent protection and eventual generic entry when patents expire, recent government chemical bans reportedly not affecting operations, faster product registration timelines, and pending biostimulant approvals under the Fertilizer Control Order.